GEArray S Series Human Immunology Signaling Pathways Gene Array: AR-SAHS-605
FG Grouping, A Molecules, I ICAM, CS Molecules, C … - eurogentec.com
... BTK, C20orf97, CTMP, GNB1, GRB2, GRB10, HSPB1, HSPCA, HSPCB, ILK, IMPDH1, INPP5D ...
IRF1, ISGF3G, JUN, JUNB, MADH4, MAPKAPK2, MAPKAPK3, MAX, MEF2A, MEF2B, MEF2C ...
View as HTML - Web Search - eurogentec.be

Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol … - Full text - MIT Libraries
I Gonzalez, G Tripathi, EJ Carter, LJ Cobb, DA … - Mol Cell Biol, 2004 - pubmedcentral.nih.gov
... In particular, p38 transactivates MEF2A and MEF2C via direct phosphorylation (66 ...
Possible candidates for PDK2 include integrin-linked kinase (ILK) (45), MK2 (47 ...
Cited by 9 - Web Search - mcb.asm.org - ncbi.nlm.nih.gov - ncbi.nlm.nih.gov

ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological … - Full text - MIT Libraries
PP Roux, J Blenis - Microbiol. Mol. Biol. Rev, 2004 - pubmedcentral.nih.gov
... several cellular targets, including cytosolic phospholipase A2, the microtubule-
associated protein Tau, and the transcription factors ATF1 and -2, MEF2A, Sap-1 ...
Cited by 28 - Web Search - cellbio.med.harvard.edu - dx.doi.org - mmbr.asm.org - all 5 versions »

Treating neurodegenerative conditions through the understanding of neuronal apoptosis.
SR D'Mello, PC Chin - Current Drug Targets-CNS & Neurological Disorders, 2005 - ingentaconnect.com
Page 1. Current Drug Targets - CNS & Neurological Disorders, 2005, 4, 3-23 3 Treating
Neurodegenerative Conditions Through the Understanding of ...
Web Search - ncbi.nlm.nih.gov - Get it from MIT Libraries